Intravascular Stents Market Size & Share, By Type (Drug Eluting Stents, Bare Metal Stents), Mode of Delivery, Product, End-Use, Regional Forecast, Industry Players, Growth Statistics Report 2024-2032

Market Outlook:

Intravascular Stents Market exceeded USD 13.4 Billion in 2023 and is expected to exceed USD 27.01 Billion by end of the year 2032, observing around 8.1% CAGR between 2024 and 2032.

• Base Year Value (2023): USD 13.4 Billion
• CAGR (2024-2032): 8.1%
• Forecast Year Value (2032): USD 27.01 Billion
• Historical Data Period: 2019-2023
• Largest Region: North America
• Forecast Period: 2024-2032

Market Dynamics:

Growth Drivers & Opportunity:

Technological advancements in stent design and materials have significantly improved the outcomes of stent procedures by reducing the risk of restenosis and enhancing patient comfort. This innovation has fueled the demand for intravascular stents and is expected to drive market growth in the coming years.

Increase in prevalence of cardiovascular diseases, such as coronary artery disease, has led to a higher demand for treatment options like intravascular stents. The rising geriatric population and unhealthy lifestyle habits are contributing to the increasing burden of cardiovascular diseases, thereby creating a favorable market environment for intravascular stents.

Growing adoption of minimally invasive procedures for the treatment of cardiovascular diseases is another major growth driver for the intravascular stents market. Minimally invasive techniques offer benefits such as shorter recovery times, reduced risk of complications, and improved patient outcomes, which are driving the demand for intravascular stents.

Report Scope

Report Coverage	Details
Segments Covered	Type, Mode Of Delivery, Product, End-Use
Regions Covered	• North America (United States, Canada, Mexico) • Europe (Germany, United Kingdom, France, Italy, Spain, Rest of Europe) • Asia Pacific (China, Japan, South Korea, Singapore, India, Australia, Rest of APAC) • Latin America (Argentina, Brazil, Rest of South America) • Middle East & Africa (GCC, South Africa, Rest of MEA)
Company Profiled	Boston Scientific, Medtronic, Terumo Medical, Abbott, Biotronik, Lifetech, iVascular SLU, Stryker, Cook Medical, Microport Scientific, Stentys S.A., Hellman & Friedman, B Braun Melsungen AG

Industry Restraints:

Stringent regulatory requirements for stent approval and reimbursement challenges are major restraints for the intravascular stents market. The lengthy and costly approval process for stents can act as a barrier for market growth, while insurers' reluctance to cover the high costs of stent procedures can limit patient access to these devices.

Increasing competition from alternative treatment options, such as drug therapy and surgical interventions, poses a challenge to the growth of the intravascular stents market. Patients and healthcare providers have a wide range of treatment options available for cardiovascular diseases, and the preference for non-invasive or less costly treatments could impact the demand for intravascular stents.

Regional Forecast:

North America:

U.S. market for intravascular stents is characterized by the high prevalence of cardiovascular diseases and the presence of a well-established healthcare infrastructure. Key players such as Medtronic and Abbott Laboratories dominate the market with their innovative products and strong distribution networks.

Canada, on the other hand, has a smaller market for intravascular stents compared to the U.S. However, the market is steadily growing due to an increase in the geriatric population and rising awareness about cardiac diseases. Companies like Boston Scientific and Cook Medical have a significant presence in the Canadian market.

Asia Pacific:

In China, the intravascular stents market is witnessing rapid growth primarily due to the large patient pool and increasing healthcare expenditure. Domestic players such as MicroPort and Lepu Medical are competing with global players like Boston Scientific and Medtronic for market share.

Japan has a mature market for intravascular stents with a strong focus on technological advancements and product innovation. Companies such as Terumo and BIOTRONIK are key players in the Japanese market, catering to the needs of patients with coronary artery diseases.

South Korea is also a key market for intravascular stents in Asia Pacific, with a growing demand for minimally invasive procedures. Local companies like NanoCruz and ITGI Medical are gaining traction in the market along with multinational players like Abbott Vascular and B. Braun.

Europe:

The United Kingdom has a well-established market for intravascular stents, with a high adoption rate of advanced medical technologies. Companies such as Biotronik and Terumo Corporation have a strong presence in the UK market, providing a wide range of stents for coronary and peripheral interventions.

Germany, known for its expertise in medical device manufacturing, is a key market for intravascular stents in Europe. Players like B. Braun and Medtronic dominate the market with their innovative products and strong research and development capabilities.

France is also a significant market for intravascular stents, with a growing focus on minimally invasive procedures and personalized medicine. Local players like Hexacath and global players like Boston Scientific are actively involved in meeting the growing demand for stents in the French market.

Segmentation Analysis:

In terms of segmentation, the global Intravascular Stents market is analyzed on the basis of Type, Mode Of Delivery, Product, End-Use.

Intravascular Stents Market:

The global intravascular stents market is segmented by type, mode of delivery, product, and end-use.

Drug Eluting Stents:

Drug eluting stents segment is expected to witness significant growth due to the increasing prevalence of cardiovascular diseases and the growing adoption of minimally invasive procedures. These stents are coated with medication to prevent restenosis and improve patient outcomes.

Bare Metal Stents:

Bare metal stents are also a prominent segment in the market, especially in emerging economies where cost plays a crucial role in treatment decisions. These stents are known for their simplicity and ease of use, making them a preferred choice in certain patient populations.

Mode of Delivery:

The market is further segmented based on the mode of delivery, including balloon expandable stents and self-expandable stents. Balloon expandable stents are widely used for precise placement and controlled deployment, while self-expandable stents offer flexibility and adaptability in complex anatomies.

Product:

The intravascular stents market is diversified based on product types such as coronary stents, peripheral stents, and neurovascular stents. Coronary stents hold the largest market share, driven by the high incidence of coronary artery diseases and the availability of advanced technologies for stent placement.

End-Use:

Hospitals, cardiac centers, and ambulatory surgical centers are key end-users in the intravascular stents market. Hospitals dominate the market share due to the availability of skilled healthcare professionals, advanced infrastructure, and the rising number of coronary intervention procedures performed in hospital settings.

Competitive Landscape:

The competitive landscape in the Intravascular Stents Market is characterized by a mix of established companies and emerging players focusing on technological advancements and product differentiation to secure a larger market share. Key strategies include extensive research and development initiatives, partnerships for innovative product offerings, and geographic expansion to penetrate emerging markets. Major players are investing in drug-eluting stents and biocompatible materials to enhance the performance and safety of their products. The competitive rivalry is elevated due to the presence of various manufacturers across different regions, leading to aggressive pricing strategies and marketing campaigns to attract healthcare providers and patients alike.

Top Market Players

- Medtronic

- Abbott Laboratories

- Boston Scientific

- B. Braun Melsungen AG

- Johnson & Johnson

- Terumo Corporation

- Cook Medical

- Cordis Corporation (a Cardinal Health company)

- Stentys S.A.

- Spectranetics